The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    psilocybin | methamphetamine
Previous Study | Return to List | Next Study

Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05322954
Recruitment Status : Recruiting
First Posted : April 12, 2022
Last Update Posted : May 14, 2024
Sponsor:
Collaborator:
Revive Therapeutics, Ltd.
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2025
Estimated Study Completion Date : May 2025